The focus in antioxidant research is on enzyme derivative investigations. Extracellular superoxide dismutase (EC-SOD) is of particular interest, as it demonstrates in vivo the protective action against development of atherosclerosis, hypertension, heart failure, diabetes mellitus. The reliable association of coronary artery disease with decreased level of heparin-released EC-SOD was established in clinical research. To create a base for and to develop antioxidant therapy, various SOD isozymes, catalase (CAT), methods of gene therapy, and combined applications of enzymes are used. Covalent bienzyme SODCHS- CAT conjugate (CHS, chondroitin sulphate) showed high efficacy and safety as the drug candidate. There is an evident trend to use the components of glycocalyx and extracellular matrix for target delivery of medical substances. Development of new enzyme antioxidants for therapeutic application is closely connected with progress in medical biotechnology, pharmaceutical industry, and bioeconomy.
Reactive oxygen species, enzyme antioxidants, oxidative stress, cardiovascular diseases, vascular wall injury, endothelial glycocalyx, extracellular superoxide dismutase, catalase, novel bienzyme superoxide dismutase – chondroitin sulphate – catalase conj
Alexander V. Maksimenko, Institute of Experimental Cardiology, Russian Cardiology Research-and-Production Complex, 3- rd Cherepkovskaya Street 15A, 121 552 Moscow, Russia Tel. +7.495.414.60.25 – Fax: +7.499.726.31.16. E-mail: firstname.lastname@example.org
Share this Article
Related Content In Devices
New Consumer Guidance on Wearable Devices from the Consumer Electronics Show 2020
Heart International. 2020;14(1):9-10 DOI: https://doi.org/10.17925/HI.2020.14.1.9
The current landscape of wearable technology is one of the most exciting and rapidly changing fields in medicine, especially for the general consumer.1 The potential of capturing a wider and deeper range of personal health information is vast, allowing for changes in care to a more personalised approach across all therapy areas. Cardiology, in particular, […]
Quantification of Seasonal Variation in Daily Physical Activity in Individuals with Heart Failure and Implantable Cardioverter Defibrillator/Cardiac Resynchronisation Therapy Devices
Heart International. 2019;13(2):31–7
In individuals with heart failure (HF) who also have implanted cardioverter defibrillators and/or cardiac resynchronisation therapy (ICD/CRT) devices, low daily physical activity (PA) levels lead to increased risk of mortality, poor aerobic capacity and lower health-related quality of life.1 Improving daily PA in these individuals may, therefore, be an important clinical endpoint; however, designing interventional […]
His Bundle Pacing – Why Should You be Doing it?
European Journal of Arrhythmia & Electrophysiology. 2019;5(2):72–6 DOI: https://doi.org/10.17925/EJAE.2019.5.2.72
It is well established that chronic right ventricular apical pacing may have an adverse effect on left ventricular systolic function,1,2 leading, in the long term, to adverse clinical outcomes such as heart failure,3 atrial fibrillation4,5 and even death.6 As an alternative to right ventricular apical pacing, the interventricular septum or right ventricular outflow tract have […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!